Show simple item record

dc.contributor.advisorOh, Seung
dc.contributor.authorHo, Jennifer
dc.contributor.authorHo, Victoria
dc.contributor.authorKwak, Bona
dc.contributor.authorNguyen, Bethany
dc.date.accessioned2022-06-29T17:10:25Z
dc.date.available2022-06-29T17:10:25Z
dc.date.issued2020
dc.identifier.urihttp://hdl.handle.net/10150/665250
dc.descriptionClass of 2020 Abstract and Poster
dc.description.abstractSpecific Aims Specific aim #1: Assess patients' knowledge of schedule II prescription opioids and awareness of opioid epidemic. Specific Aim #2: Identify demographic factors are associated with red cap intervention. Methods This prospective, observational study used data obtained through questionnaires with patients who were recruited at two Fry's community pharmacies (store numbers 611 and 115) in Mesa, Arizona. Total of 205 completed questionnaire forms were collected and patients categorized into those who recognize the red cap implementation on schedule II prescription opioid versus those who did not recognize the change of implementation. Patients who were answered questionnaires correctly 6 or more out of 11 questions were considered more knowledgeable and aware of opioid in this study. Chi-square test was used to evaluate statistical significance (P value less than 0.05). Main Result Statistical analysis by Chi Square test detected a significant difference in knowledge, awareness level, age, ethnicity, gender and occupation in patients who recognized the change of red caps on schedule II prescription opioids versus those who did not (P equals 0.03). Conclusion Patients who recognized the implementation of red caps on schedule II prescription opioids are associated with more knowledge and increased awareness regarding opioids and its adverse effects. Also, those who are younger than 50 years of age, Caucasian, female, and work in healthcare-related fields are found to be more knowledgeable and aware of opioid use compared to the other group.
dc.language.isoen
dc.publisherThe University of Arizona.
dc.rightsCopyright © is held by the author.
dc.rights.urihttp://rightsstatements.org/vocab/InC/1.0/
dc.subjectRed cap intervention
dc.subjectMesa
dc.subjectArizona
dc.subjectschedule II prescription opioid
dc.subjectadverse effects
dc.subject.meshadverse effects
dc.subject.meshopioid
dc.titleRed Cap Implementation on Schedule II Prescription Opioids in Arizona
dc.typePoster
dc.typetext
dc.contributor.departmentCollege of Pharmacy, The University of Arizona
dc.description.collectioninformationThis item is part of the Pharmacy Student Research Projects collection, made available by the College of Pharmacy and the University Libraries at the University of Arizona. For more information about items in this collection, please contact Jennifer Martin, Librarian and Clinical Instructor, Pharmacy Practice and Science, jenmartin@email.arizona.edu.
refterms.dateFOA2022-06-29T17:10:25Z


Files in this item

Thumbnail
Name:
PHR_2020_Poster_Group47.pdf
Size:
315.8Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record